ReviewJournal of enzyme inhibition and medicinal chemistry2021

New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insights.

Ahmed Elkamhawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.